Corporate America Cut Big Checks to Trump. Now CEOs Fear Subpoenas Are Coming.

Summary

The article discusses corporate America's campaign contributions to Trump and potential legal consequences for CEOs, but contains no biotech-specific news, clinical data, regulatory decisions, or material financial information relevant to pharmaceutical companies.